Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Learn about the credit cards that provide the best travel perks, ensuring you get the most value for your adventures.
24,034 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
As July 29 approaches, investors eye Microsoft’s Q4 results for a potential breakout. This article lays out why the s...
Kalshi unveils a new prediction market to price future GPU computing power, positioning compute oil as a key asset cl...
Rowe Price unveils an actively managed multi-crypto ETF on NYSE Arca, signaling traditional fund managers’ growing ap...
Amazon enters the back half of 2026 with sustained AWS growth, a scaling silicon stack, and a resilient Prime-driven ...
Tech markets climbed on Feb 19, 2026 as cloud names led the gains. Analysts point to AI demand, enterprise migrations...
A major fund trimmed its AvePoint stake, triggering a sharp move in AVPT. This piece breaks down what happened, why i...
Tesla stock has dipped below $400 again, prompting questions about a potential buy. This guide weighs growth drivers ...
Bitcoin stabilized near $65,000 after a two-day slide, supported by renewed ETF inflows and a shift in options positi...
XRP bucked a broad market drift as sentiment surged to a five-week high, even as Bitcoin struggled in a bear market. ...
Markets opened lower as geopolitical tensions with Iran intensified, sending risk assets lower while energy and defen...
As markets shift in early 2026, dividend-growth stocks offer retirees predictable income. Here are four blue chips wi...